These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30244535)

  • 1. Early restenosis of resorbable magnesium scaffolds: Optical coherence tomography findings.
    García-Guimaraes M; Antuña P; Cuesta J; Alfonso F
    Catheter Cardiovasc Interv; 2019 Jan; 93(1):79-81. PubMed ID: 30244535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe focal restenosis 15 months after implantation of a magnesium bioresorbable scaffold.
    McCutcheon K; Bennett J; Marynissen T; Adriaenssens T
    Acta Cardiol; 2020 Feb; 75(1):85-86. PubMed ID: 30735472
    [No Abstract]   [Full Text] [Related]  

  • 3. Magmaris very late in-scaffold restenosis: Has the "black boxes" nightmare come back?
    Bayón J; Santás-Álvarez M; Ocaranza-Sánchez R; González-Juanatey C
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):E174-E176. PubMed ID: 31763757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-Year Follow-Up OCT Images of 2 Bifurcation Lesions Treated With Bioresorbable Vascular Scaffolds.
    Kawamoto H; Panoulas VF; Sato K; Miyazaki T; Latib A; Colombo A
    JACC Cardiovasc Imaging; 2015 May; 8(5):617-618. PubMed ID: 25457765
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of Early Healing Profile and Neointimal Transformation Over 24 Months Using Longitudinal Sequential Optical Coherence Tomography Assessments and 3-Year Clinical Results of the New Dual-Therapy Endothelial Progenitor Cell Capturing Sirolimus-Eluting Combo Stent: The EGO-Combo Study.
    Lee SW; Lam SC; Tam FC; Chan KK; Shea CP; Kong SL; Wong AY; Yung A; Zhang LW; Tse HF; Wu KK; Chan R; Haude M; Mehran R; Mintz GS; Maehara A
    Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27418609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
    Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM
    Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenging treatment of in-stent restenosis in a coronary bifurcation by implantation of a bioresorbable scaffold under optical coherence tomography guidance.
    Zuk G; Ciecwierz D; Drewla P; Gruchała M; Gutiérrez-Chico JL; Jaguszewski M
    Cardiol J; 2019; 26(3):304-306. PubMed ID: 31246271
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe Neointimal Hyperplasia of Neoplastic Carina Following Bioresorbable Scaffold Implantation Using T-Stenting and Small Protrusion Technique: Insights From Optical Frequency Domain Imaging.
    Kawamoto H; Ruparelia N; Figini F; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Nov; 8(13):e207-9. PubMed ID: 26476605
    [No Abstract]   [Full Text] [Related]  

  • 9. Serial invasive imaging follow-up of the first clinical experience with the Magmaris magnesium bioresorbable scaffold.
    Tovar Forero MN; van Zandvoort L; Masdjedi K; Diletti R; Wilschut J; de Jaegere PP; Zijlstra F; Van Mieghem NM; Daemen J
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):226-231. PubMed ID: 31033171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
    Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
    Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial Sub-Study.
    Hideo-Kajita A; Garcia-Garcia HM; Haude M; Joner M; Koolen J; Ince H; Abizaid A; Toelg R; Lemos PA; von Birgelen C; Christiansen EH; Wijns W; Neumann FJ; Kaiser C; Eeckhout E; Teik LS; Escaned J; Azizi V; Kuku KO; Ozaki Y; Dan K; Waksman R
    Cardiovasc Revasc Med; 2019 May; 20(5):392-398. PubMed ID: 31079817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of Drug-Eluting Absorbable Metal Scaffold Restenosis: A Serial Optical Coherence Tomography Study.
    Ueki Y; Räber L; Otsuka T; Rai H; Losdat S; Windecker S; Garcia-Garcia HM; Landmesser U; Koolen J; Byrne R; Haude M; Joner M
    Circ Cardiovasc Interv; 2020 Mar; 13(3):e008657. PubMed ID: 32093514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unfavorable bioresorbable vascular scaffold resorption, a cause of restenosis?
    Ishida K; Giacchi G; Brugaletta S; García-Álvarez A; Sabaté M
    Cardiovasc Revasc Med; 2016 Dec; 17(8):571-573. PubMed ID: 27345841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early collapse causing stenosis in a resorbable magnesium scaffold.
    Marynissen T; McCutcheon K; Bennett J
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):310-312. PubMed ID: 30019823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioresorbable vascular scaffold restenosis: intravascular imaging evaluation.
    Fabris E; Kilic ID; Caiazzo G; Serdoz R; Foin N; Sinagra G; Di Mario C
    J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e132-e135. PubMed ID: 26599682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of acute scaffold recoil after implantation of the everolimus-eluting bioresorbable scaffold: an optical coherence tomography assessment in native coronary arteries.
    Sato T; Jose J; El-Mawardy M; Sulimov DS; Tölg R; Richardt G; Abdel-Wahab M
    Int J Cardiovasc Imaging; 2017 Feb; 33(2):145-152. PubMed ID: 27761749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Collapse of a Magnesium Bioresorbable Scaffold.
    Cubero-Gallego H; Vandeloo B; Gomez-Lara J; Romaguera R; Roura G; Gomez-Hospital JA; Cequier A
    JACC Cardiovasc Interv; 2017 Sep; 10(18):e171-e172. PubMed ID: 28935085
    [No Abstract]   [Full Text] [Related]  

  • 19. The OCT-ORION Study: A Randomized Optical Coherence Tomography Study Comparing Resolute Integrity to Biomatrix Drug-Eluting Stent on the Degree of Early Stent Healing and Late Lumen Loss.
    Lee SWL; Tam FCC; Lam SCC; Kong SL; Shea CP; Chan KKW; Wong MKL; Chan MPH; Wong AYT; Yung ASY; Lam YM; Zhang LW; Wu KKY; Mintz GS; Maehara A
    Circ Cardiovasc Interv; 2018 Apr; 11(4):e006034. PubMed ID: 29654119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1.
    Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.